Accomplishments and perspectives of immunological interventions in lymphoproliferative disorders
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2004-03-01 / J. Exp. Clin. Cancer Res. 2004 Mar;23(1):9-13Tumor-derived heat shock protein 70-pulsed dendritic cells elicit tumor-specific cytotoxic T lymphocytes (CTLs) and tumor immunity
/in Dendritic Cells, Hyperthermia, International Publications /von 2004-03-01 / Cancer Sci. 2004 Mar;95(3):248-53Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study
/in Breast Cancer, Dendritic Cells, International Publications /von 2004-02-25 / Cancer Immunol Immunother 2004 Jul;53(7):633-41Thyroglobulin-pulsed human monocyte-derived dendritic cells induce CD4+ T cell activation
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2004-01-01 / Int. J. Mol. Med. 2004 Jan;13(1):33-9Dendritic cell-based therapeutics for breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2004-01-01 / Breast Dis 2004;20:65-71The immune response to breast cancer, and the case for DC immunotherapy
/in Breast Cancer, Dendritic Cells, International Publications /von 2004-01-01 / Cytotherapy 2004;6(2):154-63DC-based immunotherapy of B-cell malignancies
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2004-01-01 / Cytotherapy 2004;6(1):62-7Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2003-12-01 / Hum. Cell 2003 Dec;16(4):175-82Dendritic cell-based immunotherapy in multiple myeloma
/in Dendritic Cells, International Publications, Malignant Lymphoma, Multiple Myeloma /von 2003-12-01 / Leuk. Lymphoma 2003 Dec;44(12):2031-8
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de